BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30004574)

  • 1. A useful design utilizing the information fraction in a group sequential clinical trial with censored survival data.
    Hsu CY; Chen CH; Hsu KN; Lu YH
    Biometrics; 2019 Mar; 75(1):133-143. PubMed ID: 30004574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
    Kim K; Boucher H; Tsiatis AA
    Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of group sequential logrank tests in a maximum duration trial.
    Lan KK; Lachin JM
    Biometrics; 1990 Sep; 46(3):759-70. PubMed ID: 2242413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study duration for group sequential clinical trials with censored survival data adjusting for stratification.
    Kim K
    Stat Med; 1992 Aug; 11(11):1477-88. PubMed ID: 1329172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential monitoring of survival data with the Wilcoxon statistic.
    Lan KK; Rosenberger WF; Lachin JM
    Biometrics; 1995 Sep; 51(3):1175-83. PubMed ID: 7548701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stopping a clinical trial early: frequentist and Bayesian approaches applied to a CALGB trial in non-small-cell lung cancer.
    George SL; Li C; Berry DA; Green MR
    Stat Med; 1994 Jul 15-30; 13(13-14):1313-27. PubMed ID: 7973212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On adaptive error spending approach for group sequential trials with random information levels.
    Liu Q; Lim P; Nuamah I; Li Y
    J Biopharm Stat; 2012; 22(4):687-99. PubMed ID: 22651109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A practical simulation method to calculate sample size of group sequential trials for time-to-event data under exponential and Weibull distribution.
    Jiang Z; Wang L; Li C; Xia J; Jia H
    PLoS One; 2012; 7(9):e44013. PubMed ID: 22957040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes.
    Sugimoto T; Hamasaki T; Evans SR; Halabi S
    Lifetime Data Anal; 2020 Apr; 26(2):266-291. PubMed ID: 30980317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On information fraction for Fleming-Harrington type weighted log-rank tests in a group-sequential clinical trial design.
    Kundu MG; Sarkar J
    Stat Med; 2021 May; 40(10):2321-2338. PubMed ID: 33624861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of group sequential designs in clinical trials on the basis of detectable treatment differences.
    Schäfer H; Müller HH
    Stat Med; 2004 May; 23(9):1413-24. PubMed ID: 15116350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Weibull multi-state model for the dependence of progression-free survival and overall survival.
    Li Y; Zhang Q
    Stat Med; 2015 Jul; 34(17):2497-513. PubMed ID: 25865438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SEQPWR and SEQOPR: computer programs for design of maximum information trials based on group sequential logrank tests.
    Kim K
    Comput Methods Programs Biomed; 1995 Feb; 46(2):143-53. PubMed ID: 7796583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexible implementations of group sequential stopping rules using constrained boundaries.
    Burington BE; Emerson SS
    Biometrics; 2003 Dec; 59(4):770-7. PubMed ID: 14969454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-stage phase II survival trial design.
    Wu J; Chen L; Wei J; Weiss H; Chauhan A
    Pharm Stat; 2020 May; 19(3):214-229. PubMed ID: 31749311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computations for group sequential boundaries using the Lan-DeMets spending function method.
    Reboussin DM; DeMets DL; Kim KM; Lan KK
    Control Clin Trials; 2000 Jun; 21(3):190-207. PubMed ID: 10822118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planning and analyzing adaptive group sequential survival trials.
    Wassmer G
    Biom J; 2006 Aug; 48(4):714-29. PubMed ID: 16972724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exact sequential tests for single samples of discrete responses using spending functions.
    Stallard N; Todd S
    Stat Med; 2000 Nov; 19(22):3051-64. PubMed ID: 11113942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group sequential design for time-to-event data using the concept of proportional time.
    Phadnis MA; Mayo MS
    Stat Methods Med Res; 2020 Jul; 29(7):1867-1890. PubMed ID: 31571529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An additive boundary for group sequential designs with connection to conditional error.
    Xi D; Gallo P
    Stat Med; 2019 Oct; 38(23):4656-4669. PubMed ID: 31338847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.